These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 14147336

  • 1. [MYASTHENIA].
    FARDEAU M.
    Rev Prat; 1964 Feb 11; 14():497-511. PubMed ID: 14147336
    [No Abstract] [Full Text] [Related]

  • 2. [HOW TO TREAT MYASTHENIA].
    LAPRESLE J, BOUDIN G, GOULON M, HAMBURGER J, LHERMITTE F, PEQUIGNOT H.
    Presse Med (1893); 1964 Oct 10; 72():2459-62. PubMed ID: 14214765
    [No Abstract] [Full Text] [Related]

  • 3. [ANESTHESIA IN THYMECTOMY FOR MALIGNANT MYASTHENIA].
    NOVIKOVA RI.
    Eksp Khir Anesteziol; 1964 Oct 10; 29():73-4. PubMed ID: 14161500
    [No Abstract] [Full Text] [Related]

  • 4. Hydrolysis of neostigmine by plasma cholinesterase.
    NOWELL PT, SCOTT CA, WILSON A.
    Br J Pharmacol Chemother; 1962 Dec 10; 19(3):498-502. PubMed ID: 13939168
    [Abstract] [Full Text] [Related]

  • 5. [MYASTHENIA GRAVIS].
    VAN HOVE.
    Belg Tijdschr Geneesk; 1965 Jan 15; 21():81-4. PubMed ID: 14273382
    [No Abstract] [Full Text] [Related]

  • 6. The conservative treatment of myasthenia gravis.
    AIRD RB, CAMPBELL MB.
    Calif Med; 1950 Oct 15; 73(4):334-5. PubMed ID: 14772658
    [Abstract] [Full Text] [Related]

  • 7. Muscle relaxants--reversal agents.
    Ball C, Westhorpe RN.
    Anaesth Intensive Care; 2006 Aug 15; 34(4):415. PubMed ID: 16913334
    [No Abstract] [Full Text] [Related]

  • 8. Myasthenia gravis in a case of malignant thymoma resistant to neostigmine therapy.
    RIDER JA, McDONALD R.
    Am J Med Sci; 1950 Jan 15; 219(1):71-5, illust. PubMed ID: 15402307
    [No Abstract] [Full Text] [Related]

  • 9. [Apropos of myasthenia gravis and its treatment].
    Leroy J, Robert M, Delaunay P, Dordain M.
    Sem Hop; 1969 May 20; 45(24):1691-3. PubMed ID: 4308561
    [No Abstract] [Full Text] [Related]

  • 10. [MYASTHENIA OF OPHTHALMOPLEGIC FORM. REMARKABLE IMPROVEMENT WITH SPIROLACTONES].
    CREMIEUX A, BOUDOURESQUES J, BILLE J.
    Rev Otoneuroophtalmol; 1963 May 20; 35():110-3. PubMed ID: 14074785
    [No Abstract] [Full Text] [Related]

  • 11. RELATION BETWEEN STRUCTURE AND ACTION OF QUATERNARY AMMONIUM NEUROMUSCULAR BLOCKING AGENTS.
    TAYLOR DB, NEDERGAARD OA.
    Physiol Rev; 1965 Jul 20; 45():523-54. PubMed ID: 14337567
    [No Abstract] [Full Text] [Related]

  • 12. [Myasthenia and the thymus].
    SPATH F.
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1951 Jul 20; 267():545-7. PubMed ID: 14820268
    [No Abstract] [Full Text] [Related]

  • 13. [Toxicity and curarizing property of polymethylene bisethyltheophylline quaternary ammonium salt].
    MORIN H.
    C R Seances Soc Biol Fil; 1956 May 28; 150(1):164-6. PubMed ID: 13330318
    [No Abstract] [Full Text] [Related]

  • 14. PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF MYASTHENIA GRAVIS.
    SCHWAB RS.
    Med Clin North Am; 1963 Nov 28; 47():1511-24. PubMed ID: 14078160
    [No Abstract] [Full Text] [Related]

  • 15. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F.
    Nervenarzt; 1972 Jul 28; 43(7):341-4. PubMed ID: 4627866
    [No Abstract] [Full Text] [Related]

  • 16. The management of myasthenia.
    Williams D.
    Mod Trends Neurol; 1967 Jul 28; 4(0):269-79. PubMed ID: 5634187
    [No Abstract] [Full Text] [Related]

  • 17. [MYASTHENIA AND SPIROLACTONE].
    MAMOU H, MORGENSTEIN S.
    Sem Hop; 1964 Oct 26; 40():2478-84. PubMed ID: 14205844
    [No Abstract] [Full Text] [Related]

  • 18. [HL 8562 (Bistrimethylammoniumdecandibromide) as a muscle relaxant in the practice of narcosis].
    BARTH L, BOSSE W.
    Dtsch Gesundheitsw; 1952 Aug 14; 7(33):1043-7. PubMed ID: 13020453
    [No Abstract] [Full Text] [Related]

  • 19. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC, Biewenga JE, Van Kempen GT, De Priester JA.
    Neuropharmacology; 1993 Apr 14; 32(4):373-6. PubMed ID: 8497338
    [Abstract] [Full Text] [Related]

  • 20. [REMARKS CONCERNING THE INFLUENCE OF STRUCTURE ON THE CURARIZING ACTION OF MOLECULES CONTAINING QUATERNARY AMMONIUM GROUPS].
    KUPFER D, TSOUCARIS G.
    Therapie; 1964 Apr 14; 19():653-6. PubMed ID: 14182949
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.